Part 2 - Coronary angiography with gadofosveset trisodium: A prospective intra-subject comparison for dose optimization for 100 % efficiency imaging

Mark A. Ahlman, Fabio S. Raman, Jianing Pang, Filip Zemrak, Veit Sandfort, Scott R. Penzak, Zhaoyang Fan, Songtao Liu, Debiao Li, David A. Bluemke

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Background: Three tesla (3T) coronary magnetic resonance angiography (MRA) may be optimized using gadolinium-based contrast agents (GBCA) such as gadofosveset trisodium. The goal of this study was to evaluate if there is a qualitative or quantitative improvement in the coronary arteries with variation in contrast dose. Methods: Twenty-eight healthy volunteers were prospectively recruited for coronary MRA at 3T using a steady state injection technique for 3D radial whole-heart image acquisition with retrospective respiratory self-gating ( identifier: NCT01853592). Nineteen volunteers completed both single- and double-dose imaging instances (0.03 and 0.06 mmol/kg, respectively). Intra-individual comparison of image quality was assessed by measurement of apparent signal/contrast-to-noise ratio (aSNR/aCNR) and subjective evaluation of image quality by 2 independent reviewers. Results: The average duration of coronary MRA acquisition was 7.2 ± 1.2 min. There was significantly higher (60 %, p < 0.001) aSNR of the aorta and right/left ventricle for the double dose compared to single dose injection scheme and aSNR of the coronary arteries increased by 70 % (p < 0.001) for the double dose injection. aCNR increased by +55 % and +60 % in the ventricles and coronary arteries, respectively (p < 0.001). Overall segmental artery visualization for single dose was possible 47 % of the time, which improved to 60 % with double dose (p = 0.019), predominantly driven by improvements in more distal segment visualization (+40 % improvement in mid arterial segments, p = 0.013). Conclusions: Gadofosveset trisodium dose of 0.06 mmol/kg significantly quantitatively and qualitatively improves the coronary artery image quality compared to 0.03 mmol/kg at 3T for moderate duration (6-8 min) steady state contrast enhanced coronary MRA.

Original languageEnglish
Article number58
JournalBMC Cardiovascular Disorders
Issue number1
StatePublished - 2016


  • 3.0 Tesla
  • Gadofosveset trisodium
  • Gadolinium-based intravascular contrast agent
  • Image quality
  • MS-325
  • Navigator-based angiography
  • Respiratory motion correction
  • Whole-heart coronary magnetic resonance angiography


Dive into the research topics of 'Part 2 - Coronary angiography with gadofosveset trisodium: A prospective intra-subject comparison for dose optimization for 100 % efficiency imaging'. Together they form a unique fingerprint.

Cite this